trial
as of 2026-07-0124-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study
NCTId NCT00818298
at a glance
— · Completed
Enrollment 12 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2011-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2009-01
Primary completion
2011-01
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
David C. Mamo, MD, MScPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2011-01
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person